From our experience working in clinical trials we have firsthand experience of how closely patients are monitored during clinical trials and how adverse events are managed. In the real world, patient adverse event data is just as important in maintaining accurate safety data of a drug.
Real world drug safety data is received by pharmaceutical companies form a variety of sources and they have to meet strict guidelines and timelines to report this data to regulatory agencies as part of their approval. Drug Safety professionals struggle to keep up with the influx of adverse event cases that is increasing 20% each year!
We are helping to optimize how drug safety data is reported by automating how drug safety data is processed. Faster adverse event case processing leads to more compliant regulatory submissions which helps regulatory agencies maintain better post market drug data. We want to help provide the best current data on the safety risks for approved drugs for patients and prescribers.